{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:49:21Z","timestamp":1789015761226,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA152374"],"award-info":[{"award-number":["CA152374"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.clml.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T14:52:44Z","timestamp":1411915964000},"page":"177-186.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Determining the Clinical Significance of Monoclonal Gammopathy of Undetermined Significance: A SEER\u2013Medicare Population Analysis"],"prefix":"10.1016","volume":"15","author":[{"given":"Ronald S.","family":"Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D.","family":"Gundrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan M.","family":"Neuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2014.09.004_bib1","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2014.09.004_bib2","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/leu.2009.134","article-title":"Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis","volume":"23","author":"Landgren","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2014.09.004_bib3","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/blood-2009-06-229120","article-title":"A\u00a0monoclonal gammopathy in search of clinical significance: 57 years later","volume":"114","author":"Go","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.004_bib4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A\u00a0long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2014.09.004_bib5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.004_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","article-title":"Monoclonal gammopathy of undetermined significance","volume":"134","author":"Kyle","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2014.09.004_bib7","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.004_bib8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2014.09.004_bib9","unstructured":"SEER-Medicare Linked Database. National Cancer Institute Web site. Available at: http:\/\/healthservices.cancer.gov\/seermedicare\/. Accessed May 15,\u00a02014."},{"key":"10.1016\/j.clml.2014.09.004_bib10","series-title":"Area Health Resource File (AHRF)","year":"2012"},{"key":"10.1016\/j.clml.2014.09.004_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clml.2014.09.004_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2141.2006.06441.x","article-title":"Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease","volume":"136","author":"Pineda-Roman","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2014.09.004_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejim.2010.08.010","article-title":"Survival of cancer patients with prior monoclonal gammopathy of undetermined significance","volume":"21","author":"Gregersen","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clml.2014.09.004_bib14","unstructured":"Chronic Conditions Data Warehouse (CCW). Available at: https:\/\/www.ccwdata.org\/web\/guest\/home. Updated 2013. Accessed May 15,\u00a02014."},{"key":"10.1016\/j.clml.2014.09.004_bib15","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2010-04-277566","article-title":"Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications","volume":"116","author":"Bianchi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2014.09.004_bib16","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"7 suppl","key":"10.1016\/j.clml.2014.09.004_bib17","first-page":"19","article-title":"Economic and clinical impact of multiple myeloma to managed care","volume":"14","author":"Cook","year":"2008","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.clml.2014.09.004_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2014.09.004_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2362.2007.01903.x","article-title":"Cytogenetic patterns in multiple\u00a0myeloma after a phase of preceding MGUS","volume":"38","author":"Kaufmann","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.clml.2014.09.004_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/10428199909058488","article-title":"Clinical features and outcome of multiple myeloma arising from the transformation of a monoclonal gammopathy of undetermined significance","volume":"34","author":"Patriarca","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2014.09.004_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2008.07069.x","article-title":"Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders","volume":"141","author":"Kumar","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2014.09.004_bib22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/leu.2012.189","article-title":"Suppression of uninvolved immunoglobulins defined by heavy\/light chain pair suppression is a risk factor for progression of MGUS","volume":"27","author":"Katzmann","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2014.09.004_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ajh.23204","article-title":"Preventive strategies in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"87","author":"Rajkumar","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2014.09.004_bib24","unstructured":"Surveillance, Epidemiology, and End Results Program. National Cancer Institute. Available at: http:\/\/seer.cancer.gov\/. Accessed August 27,\u00a02014."},{"key":"10.1016\/j.clml.2014.09.004_bib25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ajh.23753","article-title":"Use of autologous stem cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents","volume":"89","author":"Al-Hamadani","year":"2014","journal-title":"Am J Hematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014004145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014004145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:26:16Z","timestamp":1761870376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265014004145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S2152265014004145"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2014.09.004","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining the Clinical Significance of Monoclonal Gammopathy of Undetermined Significance: A SEER\u2013Medicare Population Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}